Consolidated Statement of Financial Position
Amounts as at 31 December
| (CZK million) | Note | 2014 | 2013 restated | 1.1.2013 restated |
|---|---|---|---|---|
| Total assets | F. | 209,425 | 199,477 | 194,640 |
| of which Total assets attributable to Transformed fund | D.1.1. | 88,758 | 76,728 | — |
| 1 Intangible assets | F.1. | 3,013 | 3,274 | 3,269 |
| 1.1 Goodwill | F.1.1. | 1,780 | 1,782 | 1,688 |
| 1.2 Other intangible assets | F.1.2. | 1233 | 1492 | 1581 |
| 2 Tangible Assets | F.2. | 255 | 484 | 480 |
| 2.1 Land and buildings (self used) | F.2.1. | 139 | 146 | 122 |
| 2.2 Other tangible assets | F.2.2. | 116 | 338 | 358 |
| 3 Investments | F.3. | 182,973 | 169,523 | 162,853 |
| 3.1 Investment properties | F.3.1. | 7,454 | 5,227 | 2,409 |
| 3.2 Investments in subsidiaries and associated companies | F.3.2. | 463 | 387 | 387 |
| 3.3 Held to maturity investments | – | – | – | |
| 3.4 Loans and receivables | F.3.3. | 5,942 | 3,051 | 3,131 |
| 3.5 Available-for-sale | F.3.4. | 145,869 | 133,177 | 128,961 |
| 3.6 Financial assets at fair value through profit or loss | F.3.5. | 23,245 | 27,681 | 27,965 |
of which financial assets relating to unit-linked policies | F.3.5. | 7,404 | 11,188 | 10,559 |
| 4 Reinsurance assets | F.4. | 9,977 | 10,291 | 9,735 |
| 5 Receivables | F.5. | 6,940 | 7,498 | 7,324 |
| 5.1 Receivables arising out of direct insurance operations | F.5. | 2,044 | 2,708 | 3,163 |
| 5.2 Receivables arising out of reinsurance operations | F.5. | 2,234 | 2,230 | 1,459 |
| 5.3 Trade and other receivables | F.5. | 2577 | 2178 | 2652 |
| 5.4 Current income tax receivables | F.5. | 85 | 382 | 50 |
| 6 Other assets | F.6. | 1,211 | 1,128 | 1,656 |
| 6.1 Deferred acquisition costs | F.6.1. | 782 | 752 | 1,315 |
| 6.2 Deferred tax assets | F.6.F.26.1. | 81 | 76 | 47 |
| 6.3 Other assets | F.6. | 348 | 300 | 294 |
| 7 Cash and cash equivalents | F.7. | 5,050 | 7,272 | 9,323 |
| 209,419 | 199,470 | 194,640 | ||
| 8 Assets held for sale | F.8. | 6 | 7 | |
| Total shareholders' equity and liabilities | F. | 209,425 | 199,477 | 194,640 |
| of which Total shareholders' equity and liabilities attributable to Transormed fund | D.1.1. | 88,758 | 76,728 | – |
| 1 Shareholders' equity | F.9. | 31,413 | 24,617 | 25,292 |
| 1.1 Shareholders equity attributable to the Group | F.9. | 30,756 | 23,999 | 24,848 |
| 1.1.1 Share capital | F.9. | 4,000 | 4,000 | 4,000 |
| 1.1.2 Retained earnings and other reserves | F.9. | 26,756 | 19,999 | 20,848 |
| 1.2 Shareholders equity attributable to non-controlling interest | F.9. | 657 | 618 | 444 |
| 2 Other provisions | F.10. | 826 | 1,012 | 1,256 |
| 3 Insurance liabilities | F.11. | 77,397 | 83,548 | 87,267 |
| 4 Financial liabilities | F.12. | 89,563 | 80,251 | 69,788 |
| 4.1 Financial liabilities through profit or loss | F.12. | 3,203 | 1,991 | 2,371 |
| 4.2 Other financial liabilities | F.12. | 86,360 | 78,260 | 67,417 |
| 5 Payables | F.13. | 8,574 | 8,324 | 8,618 |
| 5.1 Payables arising out of direct insurance operations | F.13. | 2192 | 2260 | 2594 |
| 5.2 Payables arising out of reinsurance operations | F.13. | 4321 | 4443 | 3658 |
| 5.3 Current income tax payables | F.13. | 301 | 13 | 702 |
| 5.4 Other payables | F.13. | 1,760 | 1,608 | 1,664 |
| 6 Other liabilities | F.14. | 1,652 | 1,725 | 2,419 |
| 6.1 Deferred tax liabilities | F.14.F.26.1. | 65 | 256 | 303 |
| 6.2 Other liabilities | F.14. | 1,587 | 1,469 | 2,116 |